Paper344347
Effect of thymidine on activity of trimethoprim and sulphamethoxazole.
Stokes A and 1 other. J Clin Pathol, 1978. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Effect of thymidine on activity of trimethoprim and sulphamethoxazole. Papers, record 344347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/344347
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sulfamethoxazole | Major topic |
| Thymidine | Major topic |
| Trimethoprim | Major topic |
| Bacteriuria | |
| Escherichia coli | |
| Humans | |
| Staphylococcus aureus |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14329476 | IMPROVED METHOD FOR THE ISOLATION OF THYMINE-REQUIRING MUTANTS OF ESCHERICHIA COLI. | J Bacteriol | 1965 | https://conductscience.org/library/papers/14329476 | PubMed |
| 2 | 871632 | Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. | Br Med J | 1977 | https://conductscience.org/library/papers/871632 | PubMed |
| 3 | 56651 | Thymine-requiring bacteria associated with co-trimoxazole therapy. | Lancet | 1976 | https://conductscience.org/library/papers/56651 | PubMed |
| 4 | 4584067 | Thymine-requiring mutants of Proteus mirabilis selected by co-trimoxazole in vivo. | J Gen Microbiol | 1973 | https://conductscience.org/library/papers/4584067 | PubMed |
| 5 | 4590994 | Letter: Co-trimoxazole resistance. | Br Med J | 1974 | https://conductscience.org/library/papers/4590994 | PubMed |
| 6 | 4570620 | Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients. | J Clin Pathol | 1972 | https://conductscience.org/library/papers/4570620 | PubMed |
| 7 | 4463825 | Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function. | Antibiot Chemother (1971) | 1974 | https://conductscience.org/library/papers/4463825 | PubMed |
| 8 | 4425219 | Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection. | J Clin Pathol | 1974 | https://conductscience.org/library/papers/4425219 | PubMed |
| 9 | 4752317 | Letter: Is co-trimoxazole bactericidal in sputum? | Br Med J | 1973 | https://conductscience.org/library/papers/4752317 | PubMed |
| 10 | 777036 | Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. | J Clin Pathol | 1976 | https://conductscience.org/library/papers/777036 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39950956 | Expanding the Landscape of Dual Action Antifolate Antibacterials through 2,4-Diamino-1,6-dihydro-1,3,5-triazines. | ACS Infect Dis | 2025 | https://conductscience.org/library/papers/39950956 | PubMed |
| 39445807 | Mechanisms of Staphylococcus aureus survival of trimethoprim-sulfamethoxazole-induced thymineless death. | mBio | 2024 | https://conductscience.org/library/papers/39445807 | PubMed |
| 39036800 | The effect of antibiotic selection on collateral effects and evolvability of uropathogenic Escherichia coli. | NPJ Antimicrob Resist | 2024 | https://conductscience.org/library/papers/39036800 | PubMed |
| 35889189 | Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method. | Microorganisms | 2022 | https://conductscience.org/library/papers/35889189 | PubMed |
| 34704796 | Phenotypic Detection of Hemin-Inducible Trimethoprim-Sulfamethoxazole Heteroresistance in Staphylococcus aureus. | Microbiol Spectr | 2021 | https://conductscience.org/library/papers/34704796 | PubMed |
| 33526491 | In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/33526491 | PubMed |
| 31591126 | Comparative In Vivo Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against Stenotrophomonas maltophilia in the Murine Thigh Model. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31591126 | PubMed |
| 29073080 | Maladaptive DNA repair is the ultimate contributor to the death of trimethoprim-treated cells under aerobic and anaerobic conditions. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/29073080 | PubMed |
| 23052313 | Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole? | J Clin Microbiol | 2012 | https://conductscience.org/library/papers/23052313 | PubMed |
| 20028816 | Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20028816 | PubMed |
| 19405550 | Community-associated meticillin-resistant Staphylococcus aureus infections: epidemiology, recognition and management. | Drugs | 2009 | https://conductscience.org/library/papers/19405550 | PubMed |
| 16811110 | Thymidine mutants. | J Clin Pathol | 1978 | https://conductscience.org/library/papers/16811110 | PubMed |
| 9145866 | Efficacy of trimethoprim in murine experimental infection with a thymidine kinase-deficient mutant of Escherichia coli. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9145866 | PubMed |
| 7427374 | Bacterial resistance to trimethoprim. | Br Med J | 1980 | https://conductscience.org/library/papers/7427374 | PubMed |
| 7261250 | Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexate. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7261250 | PubMed |
| 7049657 | Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections. | Drugs | 1982 | https://conductscience.org/library/papers/7049657 | PubMed |
| 6759092 | Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. | Drugs | 1982 | https://conductscience.org/library/papers/6759092 | PubMed |
| 3497170 | Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. | J Clin Microbiol | 1987 | https://conductscience.org/library/papers/3497170 | PubMed |
| 3494425 | Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3494425 | PubMed |
| 533255 | Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/533255 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/344347
GET https://conductscience.org/api/papers/v1/344347/cited_by?page=2